Open Text Corporation closed the week at $24.93, down nearly 3% on Friday alone after reporting earnings — and the stock finds itself in an unusual spot: an analyst upgrade landed the same day the market sold the news.
The Friday move followed earnings released August 6. Citigroup's Steven Enders responded by raising his price target to $28 from $25, keeping a Neutral rating. That's a meaningful signal — a bellwether firm lifting its target immediately after a post-earnings selloff suggests Citi sees the decline as overdone relative to the fundamentals. The broader analyst community remains cautious, however. Most recent target changes from Barclays, RBC Capital, and Scotiabank have been to the downside, with cuts clustering around the May earnings cycle. Scotiabank's target of $40 looks notably out of step with the current $24.93 price — that gap likely reflects dated assumptions rather than current Street conviction. The consensus sits at Hold, and the direction of travel over the past six months has been one of modest target compression, not expansion.
The bull case rests on cloud bookings momentum — enterprise cloud up 10% year-over-year to $772 million in FY25 — and a valuation that screens cheap even for enterprise software. The P/E sits near 5x and EV/EBITDA near 5.7x. EPS momentum is a standout: the 30-day and 90-day forward earnings momentum scores rank in the 90th and 85th percentiles respectively against the broader universe. The bear case is harder to dismiss. Organic growth is tracking below consensus, leverage remains elevated at 2.9x net debt/EBITDA, and the Application Development and Maintenance segment has shown sustained revenue pressure. Factor scores tell a mixed story — high dividend and EPS momentum rankings, but a short score rank in the 36th percentile and a combined ORTEX score of 41 suggest this isn't a name where momentum is doing the heavy lifting.
Short positioning is modest and easing, which actually cuts against any squeeze narrative. Short interest sits at 4.8% of free float — not trivial, but down roughly 2% on the week and only marginally higher than the month-ago baseline before a late-July build. The ORTEX short score has drifted lower through the week, from 42.2 on August 4 to 41.4 by August 6, indicating the market's short conviction is fading rather than intensifying. Borrow conditions are extremely loose: availability is running at over 820% — meaning there are roughly eight shares available for every one currently shorted — and cost to borrow has fallen back to around 0.5% after briefly spiking above 0.8% in mid-July. Nothing in the lending market suggests any pressure building.
Options positioning is equally calm. The put/call ratio of 0.65 sits just above its 20-day mean of 0.63, a z-score of less than 0.7 — barely a nudge from neutral. There is no elevated demand for downside protection relative to recent history, despite the stock's Friday decline. Peers moved sharply in contrast: SPT surged 26% on the day and 20% on the week, while CRM and BOX gained 3-5% over the same period. OTEX's underperformance against its software peer group this week was notable.
The institutional register is dominated by Canadian managers — 1832 Asset Management, Brandes, Manulife, and Letko Brosseau collectively hold a substantial chunk of the float — and recent changes have been incremental rather than directional. Insider activity has been a steady drip of small executive sales at the EVP level through May and June, nothing in size or seniority that changes the narrative.
What to watch next: with no next earnings date flagged in the data, the near-term focus shifts to whether the Citigroup target lift draws any follow-through from other Street participants, and whether the gap between current price and the Scotiabank $40 target gets reassessed as the leverage reduction timeline becomes clearer.
See the live data behind this article on ORTEX.
Open OTEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
